Inhibit or destroy? Why PROTAC technology is emerg...
Unlock new parts of the proteome with PROTAC, a promising emerging techn...
Life Science stories
Impact of FGFRs dysregulation in oncogenic mechanisms
Deregulation of Fibroblast growth factor (FGF) / fibroblast growth facto...
In the treatment of Human cancer, KRAS remains an ...
The KRAS gene is a proto-oncogene that codes for a small GTPase transduc...
Ubiquitin Ser65 triggers the mechanisms of Mitophagy
Ubiquitin (Ub) is covalently bound to many misfolded, denatured, or surp...
The role of Immune dysregulation and Mitochondrial...
Critical facts about Amyotrophic Lateral Sclerosis, known as a rare dise...
Impact of Aging and Gut Microbiota on Neuroinflamm...
We show that age and gut microbiota play significant roles in neuroinfla...
New technologies in Multiple Sclerosis drug discovery
How HTRF and Alpha Technologies have contributed to MS drug discovery.
Therapeutic Strategies for Fibrotic Diseases
AlphaScreen® SureFire® pERK and HTRF® cGMP kits were used to better u...
When AlphaLISA and HTRF meet inflammatory bowel di...
Inflammation of the digestive tract wall due to an overactivation of the...